Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.5%
1w
2.3%
1m
8.1%
3m
14.0%
6m
6.0%
1y
13.8%
all
18.6%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep22Jun23Mar24Dec24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,206 0.5%
2,180
2,670
Company Overview

Sales
13,577 Cr
Growth: 20.1%
Profit after Tax
1,751 Cr
Growth: -7.5%
Large Cap
91,069 Cr
P/E: 51.7x
Industry P/E: 33.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 13,577
Growth 20.1%
EBITDA 24.2%
P/S 6.7x
Dividend 0.0%
P/E 51.7x
Book Value ₹ 370
PEG Ratio 2.6x
ROE 12.7%
P/B 6.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is India’s one of the leading pharmaceutical company with a diversified portfolio - from pharma and super specialty to consumer healthcare backed by strong in-house R&D capabilities with an established and deeply penetrated presence across India. The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)